Bunge Global S.A. (BG) Stock Analysis
Is BG a good investment?
Bunge Global S.A. (BG) has a Plutrex AI rating of 62.0/100 as of October 02, 2026, indicating a Hold consensus. The stock is not classified as halal-compliant. Key strength: PEG of 1.21 is 33% below the industry average of 1.81 — BG is the best growth-adjusted value in Agricultural Farm Products, offering faster 5-year EPS growth (17.0% vs. 14.5%) at a lower earnings multiple (P/E 20.67x vs. industry 23.37x), a dual discount that rarely persists. Main concern: FCF of -$711M against $788M cash is the binding constraint — less than one year of self-funding runway, and the $600M senior notes offering confirms continued external financing dependency; with D/E at 0.66x (vs. industry 0.47x), financial flexibility is below peers precisely when Viterra integration costs are peaking — FCF normalization is the single most critical variable for the investment thesis.
Investment Summary
Bunge Global (BG) at $106.61 represents a growth-at-discount opportunity within Agricultural Farm Products, but one constrained by structurally weak business economics and persistent negative free cash flow. The core thesis: BG trades at a PEG of 1.21 (vs. industry average 1.81 — a 33% discount), a P/E of 20.67x (vs. industry 23.37x — an 11.5% discount), and a P/B of 1.28x, all while offering superior forward EPS growth of 17.0% vs. the industry's 14.5% 5-year CAGR. Analyst consensus of $152.50 implies 43% upside. Against this: net margin of only 1.1%, negative FCF of -$711M against $788M cash (less than one year of cover), D/E of 0.66x vs. industry average 0.47x, and ROE of 7.5% that fails to clear a 10% cost of equity hurdle. News sentiment is positive at 76.7/100, with Viterra integration potential and sugar divestiture as constructive catalysts, but no breakthrough developments since the prior report. Stock has continued to slide from $110.21 to $106.61 (-3.3%) — price action remains weak. Rating unchanged at 62.0 — the investment case is intact but not compelling enough to upgrade without FCF stabilization evidence.
Key Strengths
- PEG of 1.21 is 33% below the industry average of 1.81 — BG is the best growth-adjusted value in Agricultural Farm Products, offering faster 5-year EPS growth (17.0% vs. 14.5%) at a lower earnings multiple (P/E 20.67x vs. industry 23.37x), a dual discount that rarely persists
- Analyst consensus price target of $152.50 implies 43.0% upside from $106.61, with P/B of 1.28x providing a tangible asset-backed floor (book value ~$83/share) that limits catastrophic downside — the risk-reward ratio from entry zone to analyst target is approximately 4:1
- Viterra integration potential and Brazil sugar divestiture are strategic catalysts: successful integration could expand global agribusiness footprint with meaningful synergies, while the sugar exit simplifies operations and reduces exposure to volatile Brazilian commodity markets — both support long-term earnings quality improvement
Key Concerns
- FCF of -$711M against $788M cash is the binding constraint — less than one year of self-funding runway, and the $600M senior notes offering confirms continued external financing dependency; with D/E at 0.66x (vs. industry 0.47x), financial flexibility is below peers precisely when Viterra integration costs are peaking — FCF normalization is the single most critical variable for the investment thesis
- Stock has declined from $119.31 → $110.21 → $106.61 over two reporting cycles despite consistently positive/neutral news sentiment (83.9 and 76.7 respectively) — persistent price weakness on constructive news signals either institutional distribution or the market discounting near-term earnings risk; net margin of 1.1% provides virtually no cushion if commodity spreads narrow or integration costs exceed expectations
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
BG operates with razor-thin commodity economics: gross margin 4.87% (vs. industry 6.41%, a 24% discount), operating margin 4.62% (vs. industry 3.96%, a 17% premium via cost discipline), net margin 1.10% (vs. industry 1.51%, a 27% discount due to interest burden on 0.66x D/E). ROE of 7.53% beats the industry average of 5.88% (+28% premium) but fails the 10% cost of equity threshold. The most critical weakness: FCF of -$711M against cash of $788M creates a less-than-one-year runway, confirmed by the recent $600M senior notes offering showing external financing dependency. Growth is the bull case: forward EPS of 17.0% (vs. industry 14.5%), but recent YoY EPS growth was only 7.3%, creating a 9.7-point acceleration gap that analysts must prove out. Revenue growth of 88.3% is extraordinary but almost certainly non-repeatable. P/E 20.67x, PEG 1.21, P/B 1.28x — valuation is reasonable but not deep value given the FCF deficit. The stock's 43% gap to analyst consensus ($152.50 target) reflects forward earnings power, not current earnings quality.
News Sentiment
Bunge Global finds itself at a crossroads as the agricultural giant navigates a complex landscape of trade uncertainty, strategic transformation, and integration challenges. The company recently headlined with a major debt offering — a capital markets move confirming that Bunge continues to rely on external financing as it digests its landmark Viterra acquisition, which analysts say could meaningfully reshape its global agribusiness footprint if integration goes smoothly. On the strategic front, Bunge's decision to sell its two sugarcane mills in Brazil signals a deliberate pivot away from volatile sugar markets, with the proceeds potentially helping ease the cash burn that's been a persistent concern for investors. Meanwhile, the broader agribusiness landscape is shifting: one headline asks whether Bunge could 'soar if Trump's tariffs reshape global grain flows' — a theme echoed in coverage noting that global grain flow reshaping is the primary upside driver for agribusiness companies in the current environment. Yet caution flags are flying too. Coverage comparing Bunge to rival Archer-Daniels Midland highlights integration risks even as oilseed strength provides near-term earnings support. The question of whether Bunge is 'worth buying as oilseed strength meets integration risks' captures the essential tension investors face. One analyst piece bluntly identifies what appears to be a mispricing in the stock — the company trades at a 33% PEG discount to peers despite faster forward growth. For everyday investors, the story is this: Bunge is a global food infrastructure company in the middle of a major transformation. The opportunity is real, but so is the uncertainty.
Risk Assessment
Primary risk: FCF remains deeply negative at -$711M with less than one year of cash cover ($788M) — if commodity spreads compress or Viterra integration costs overshoot, BG could face a liquidity crunch requiring dilutive equity issuance. Mitigation: D/E of 0.66x is not extreme, and the $600M notes offering extends the runway. Secondary risk: analyst 17% EPS growth projection requires a 9.7-point acceleration from the recent 7.3% YoY EPS growth — execution risk is substantial. Mitigation: oilseed processing strength (cited in prior news cycle) provides specific near-term support. Technical risk: stock has declined 10.7% from $119.31 over two weeks on neutral-to-positive news — continued institutional selling could push toward $95-100 range. Mitigation: P/B of 1.28x (book ~$83/share) creates a hard fundamental floor roughly 22% below current price. Trade risk: commodity price cycles are unpredictable; a global grain demand shock could compress spreads and make the 17% EPS growth projection unachievable. Stop at $95.50 represents approximately 10% below entry midpoint and sits just above key support levels near book value territory.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is BG a halal stock?
No, Bunge Global S.A. (BG) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for BG?
Bunge Global S.A. (BG) has a Plutrex AI rating of 62.0/100 with a Hold consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is BG a good investment?
According to Plutrex AI, BG has a Hold rating (62.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in BG?
US stocks like BG can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in BG?
Plutrex AI identifies the main risks for BG by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.